CrossBridgeBio
About CrossBridgeBio
Developing a dual payload platform for non-GLP NHP toxicity data.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
Round | Date | Amount | Investors |
---|---|---|---|
Series A | May 17, 2025 | Undisclosed | Unknown |
Founders
No founder information available.
Investors
No investor information available.
Recent Mentions
Board meeting on Monday. Series A coming into focus for @CrossBridgeBio. Data set we promised with our seed raise is finishing: Non-GLP NHP tox with our EGCit dual payload platform. We’re very encouraged by what we’re seeing! We were invited to speak at World ADC. Exciting!
Similar Startups
Spark Biomedical
86% matchSpark Biomedical is focused on developing innovative solutions for pain management and addiction tre...
Pillar Biosciences
85% matchPillar Biosciences is a biotechnology company focused on developing innovative genomic solutions for...
inductive_bio
85% matchA platform that accelerates the discovery of life-changing therapeutics using state-of-the-art AI mo...
BreachRx
85% matchBreachRx is a cybersecurity startup focused on providing innovative solutions to help organizations ...